Publish Time: 2026-10-07 Origin: Site
Content Menu
● How to Evaluate an Octinoxate Supplier
● Understanding Octinoxate Before Comparing Manufacturers
>> Material Grade: Why "99% Purity" Is Not a Complete Specification
>> Certifications: Choose Relevant Evidence
● Why Source Octinoxate Through China?
>> What Recent Industry Data Actually Show
● Top 10 Octinoxate Manufacturers and Supply Partners in China
>> 1. ZHENYIBIO TECHNOLOGY INC
>> 2. Nanjing COSMOS Chemical Co., Ltd.
>> 4. Fujian Disheng Technology Co., Ltd.
>> 5. Uniproma
>> 6. Shanghai COSROMA Biotech Co., Ltd.
>> 7. Suzhou Greenway Biotech Co., Ltd.
>> 8. Xi'an Aogu Biotech Co., Ltd.
>> 9. JIN DUN / Shanghai JIN DUN Industrial Co., Ltd.
>> 10. Shanghai Freemen Chemicals Co., Ltd.
● Comparison Table: Capacity, MOQ, and Certification Evidence
● Buyer's Guide: From Initial Inquiry to Repeat Orders
>> 1. Verify the Factory Behind the Quotation
>> 2. Qualify Samples Through a Controlled Process
>> 3. Separate Ingredient Support from Finished-Product OEM/ODM
>> 4. Define Logistics Before Shipment
● The Underdiscussed Procurement Trap: A Passing COA Can Hide a Source Change
● Regulatory Considerations for International Buyers
>> European Union: Use the Final Assessment, Not an Outdated Preliminary Headline
>> United States: Distinguish Existing Marketing Conditions from Proposed Changes
● Conclusion: Select the Supplier That Matches Your Procurement Model
>> 1. How Can I Check Whether an ISO Certificate Has Expired or Been Suspended?
>> 2. Can Two Octinoxate Batches with the Same Assay Produce Different Results?
>> 3. How Do I Qualify a Distributor When the Factory Will Not Deal with Me Directly?
>> 4. Does a Historical FDA Inspection Mean the Ingredient Is Approved for Every US Sunscreen?
>> 5. Can a Supplier's Human-Safety Documentation Support a "Reef-Safe" Claim?
Finding a dependable Octinoxate manufacturer in China requires more than comparing prices per kilogram. Professional buyers need to understand who actually produces the material, how batch quality is controlled, whether documentation supports the intended market, and how consistently the supplier can deliver.
China offers several sourcing models: specialist UV-filter manufacturers, integrated cosmetic-ingredient businesses, and commercial suppliers working with manufacturing partners. These models serve different purchasing needs. A multinational sunscreen producer may prioritize audited production sites and supply continuity, while an emerging brand may value formulation assistance, smaller purchasing commitments, and coordinated ingredient sourcing.
This guide evaluates ten companies relevant to Chinese Octinoxate sourcing. It distinguishes documented capabilities from information that buyers must obtain directly.
Editorial disclosure: This article was prepared for ZHENYIBIO TECHNOLOGY INC, which appears first as the commissioning company. The list is a commercial procurement shortlist, not an independently audited ranking by production volume, product quality, or market share. Inclusion does not establish that every company manufactures Octinoxate in its own facility.
The most useful starting point is traceability: the ability to connect the quoted product, manufacturing site, quality records, sample, and delivered shipment.
A supplier should be assessed across six practical dimensions:
| Evaluation dimension | What buyers should examine | Why it matters |
|---|---|---|
| Manufacturing identity | Legal entity, production address, ownership or manufacturing agreement | Distinguishes an actual producer from a reseller |
| Quality systems | Current certificates, covered sites, audit records, release procedures | Establishes whether quality controls apply to the relevant operation |
| Technical capability | Analytical methods, impurity controls, formulation support | Helps identify meaningful differences between apparently similar grades |
| Supply reliability | Available allocation, maintenance schedules, inventory policy | Reduces disruption during seasonal sunscreen demand |
| Documentation | Batch COA, SDS, specification, origin and regulatory statements | Supports qualification, importation, and product development |
| Commercial flexibility | Trial-order terms, packaging options, communication process | Determines suitability for smaller brands and growing manufacturers |
This shortlist uses public company information, published product listings, specialist ingredient directories, and official regulatory or industry sources. It does not assign numerical scores because comparable audited data are unavailable for all ten companies.
Where Octinoxate-specific capacity, MOQ, or certificate validity is not publicly established, the comparison table states that limitation rather than inventing a figure.
Octinoxate is commonly identified as Ethylhexyl Methoxycinnamate, Octyl Methoxycinnamate, EHMC, or OMC. The commonly referenced CAS number is 5466-77-3. It is an oil-soluble UVB filter used in sunscreen and other personal-care formulations. Uniproma, for example, markets its Sunsafe-OMC grade under the INCI name Ethylhexyl Methoxycinnamate.
A purchasing specification should define more than an assay percentage.
Ask the supplier to document:
- Identity and the analytical method used to establish it.
- Assay limits and whether results are reported on an as-is basis.
- UV absorption performance under a defined test method.
- Appearance, color, and odor acceptance criteria.
- Water content and relevant residual solvents.
- Specified impurities and any additional destination-market requirements.
- Shelf life, storage conditions, and retest policy.
UV absorption is particularly relevant because Octinoxate is purchased for its functional performance. Uniproma's published product information specifies a minimum specific extinction of 830 at 308 nm in methanol for Sunsafe-OMC. This is a supplier-specific specification, not a universal acceptance limit for every commercial grade.
The procurement implication is straightforward: compare suppliers against the same approved specification and test conditions, rather than treating unrelated "high-purity" claims as equivalent.
For ingredient procurement, a manufacturing quality system and a suitable ingredient-production audit are more informative than a collection of unrelated certification logos.
COSMOS publicly states that it holds EFfCI certification. MFCI describes GMP workshops and cGMP management. These statements are useful starting points, but buyers should obtain current documents and confirm that their scope covers the relevant site and activity.
CE and RoHS claims should not replace cosmetic-ingredient qualification. A listing headline containing those terms does not establish that an Octinoxate batch meets your contractual specification or your finished product's regulatory requirements.
Similarly, food-safety, Halal, or Kosher credentials may be relevant to particular purchasing policies, but they do not independently establish sunscreen performance.
The practical advantage is access to both chemical-manufacturing specialists and broader cosmetic-ingredient supply networks.
The companies in this shortlist illustrate several regional capabilities:
- Nanjing and Suzhou host ingredient businesses such as COSMOS and Greenway.
- Shanghai supports commercial coordination through companies including COSROMA, JIN DUN, and Freemen.
- Fujian's Shaowu industrial park hosts Disheng's fine-chemical operation.
- Xi'an is home to ZHENYIBIO and Aogubio, both positioned around broader cosmetic and natural-ingredient portfolios.
These locations demonstrate complementary sourcing capabilities. They should not be interpreted as an independently measured ranking of China's Octinoxate production clusters.
Cosmetics Europe's Annual Report 2024, published in 2025, valued European cosmetics and personal-care retail sales at approximately €104 billion in 2024. This provides context for the scale of downstream beauty demand; it is not an Octinoxate market-size estimate.
China's General Administration of Customs reported that total cosmetics imports and exports reached RMB 171.61 billion in 2025, up 2.7% year on year. That figure combines imports and exports and concerns cosmetics broadly. It must not be presented as Chinese Octinoxate exports or UV-filter manufacturing revenue.
For purchasing decisions, these broader figures are useful context. Supplier qualification still depends on product-specific evidence.
Established: 2012
Location: Xi'an, Shaanxi
Market coverage: The company reports sales across more than 50 countries, including markets in Asia, Europe, and the Americas.
ZHENYIBIO is relevant to buyers seeking a broader cosmetic-ingredient relationship rather than an isolated UV-filter transaction. Its published portfolio includes Octinoxate alongside other functional cosmetic ingredients.
The company describes a 10,000-square-meter production area and a 1,500-square-meter research and development center. Its stated quality-control activities include assay, water-content, heavy-metal, residual-solvent, and microbiological testing. These are company-reported capabilities, not independently verified Octinoxate production figures.
For smaller brands, its proposed value is coordinated ingredient purchasing, research-oriented support, and OEM/ODM project communication. Those services should be defined in a written scope covering sample development, technical questions, documentation, packaging, and responsibility for final-product testing.
Buyer fit: Brands and manufacturers seeking consolidated ingredient sourcing and a collaborative development relationship.
Qualification priority: Confirm whether the offered Octinoxate is produced internally or sourced through a partner. Request its actual production site, batch specification, available allocation, and current applicable certificates. Evaluate cost-effectiveness through a project-specific quotation rather than assuming it from company positioning.
Established: 2000
Location: Nanjing, Jiangsu
Market orientation: Personal-care raw materials and international ingredient supply.
COSMOS specializes in research, production, and sales of personal-care ingredients. Public company information identifies production bases in Suqian and Ma'anshan, providing a more substantial manufacturing footprint than a sales-office listing alone.
Its public statement concerning EFfCI certification makes it relevant to buyers whose qualification programs emphasize cosmetic-ingredient manufacturing controls. Nevertheless, the certificate and the specific offered Octinoxate grade must be checked directly.
Buyer fit: Procurement teams considering a manufacturing-oriented personal-care ingredient partner.
OEM/ODM scope: Treat its documented business primarily as ingredient supply and technical development. Finished sunscreen private-label manufacturing should not be assumed.
Qualification priority: Obtain the current Octinoxate product dossier, identify the releasing production site, and confirm destination-market documentation and available annual allocation.
Established: 1993
Location: China, with a multi-site UV-absorber manufacturing network
Market orientation: UV filters and UV absorbers, supported by international logistics infrastructure.
MFCI is one of the clearest specialist UV-filter candidates in this shortlist. Its Octinoxate appears in UL Prospector's personal-care ingredient directory.
The company reports four production bases, four overseas warehousing and logistics centers, and more than 800 employees. Those figures describe the company overall; they do not establish Octinoxate-specific production capacity.
MFCI also describes GMP workshops and a historical US FDA on-site audit. Buyers should distinguish such an audit history from approval of every ingredient or finished sunscreen product.
Buyer fit: Manufacturers prioritizing UV-filter specialization and continuity planning.
OEM/ODM scope: Ingredient supply and UV-filter technical services are the relevant starting points. Confirm separately whether any requested custom blends or finished-product services are available.
Qualification priority: Request site-specific quality documents, recent batch trends, production allocation, and contingency plans.
Established: 2017
Location: Shaowu, Fujian
Market orientation: UV absorbers, light stabilizers, cosmetic UV filters, and custom formulations.
Disheng identifies itself as a fine-chemical manufacturer located in Jintang Industrial Park. Its business builds on earlier chemical operations and includes a published DSUNPRO OMC product listing for Octinoxate.
Its specialist chemical orientation makes it a candidate for buyers who want to discuss product specifications directly with a manufacturing-focused business.
Buyer fit: Bulk ingredient buyers comparing dedicated chemical-production partners.
OEM/ODM scope: Custom formulations are publicly mentioned, but buyers must clarify whether that means ingredient blends, application solutions, or finished cosmetics.
Qualification priority: Obtain cosmetic-grade specifications and supporting controls. Do not treat experience in industrial UV absorbers as automatic evidence that every offered grade is suitable for personal-care use.
Established: 2005 in Europe; its history records a Chinese plant partnership beginning in 2008
China connection: Manufacturing participation and ingredient supply operations
Market orientation: International cosmetics, pharmaceutical, and industrial customers.
Uniproma should be described accurately as an international business with Chinese manufacturing involvement, rather than simply as a company founded in China.
Its Sunsafe-OMC listing provides identifiable product information, including the INCI name, CAS number, and UV absorption specification. This makes it useful for buyers comparing technical documentation rather than generic marketplace descriptions.
Buyer fit: Formulators seeking a named UV-filter grade and a broader sun-care ingredient portfolio.
OEM/ODM scope: Ingredient application support and formulation-related services should be discussed directly. A finished-product private-label program is not established by the OMC listing.
Qualification priority: Confirm the manufacturing origin of the quoted grade, the contracting entity, local inventory availability, and the certificate scope applicable to the supplied batch.
Established: 2017
Location: Shanghai
Market orientation: Global cosmetic and personal-care ingredient customers.
COSROMA explicitly describes a mixed business model: developing and manufacturing some products while also operating international business for other Chinese brands and manufacturers. This transparency helps buyers ask the right questions about production ownership.
Its UV-filter portfolio lists Ethylhexyl Methoxycinnamate as Cosroma FSJ015, and the ingredient also appears in UL Prospector.
Buyer fit: Brands and manufacturers seeking consolidated access to several Chinese ingredients.
OEM/ODM scope: Integrated ingredient supply is documented. Any custom formulation, repacking, or finished-product development service requires a separate agreed scope.
Qualification priority: Establish which factory manufactures FSJ015 and whether the quality agreement provides access to manufacturer-origin records and change notifications.
Established: 2015
Location: Suzhou, Jiangsu
Market orientation: Cosmetic and personal-care ingredients, with international supply positioning.
Greenway states that it represents two Chinese manufacturers. Buyers should therefore assess it as a supply partner with manufacturing relationships unless a specific product's production ownership is demonstrated.
UL Prospector lists its Ethylhexyl Methoxycinnamate as a 99% liquid ingredient. That listing supports product relevance, but the quoted batch still requires its own specification and analytical documentation.
Buyer fit: Purchasers evaluating a broader cosmetic-active and functional-ingredient basket.
OEM/ODM scope: Discuss application support and coordinated sourcing directly. Do not assume that a broad catalog includes complete sunscreen contract manufacturing.
Qualification priority: Obtain the manufacturing partner's name, site address, applicable certificates, and written approval requirements for changing sources.
Established: 2013, according to its corporate homepage
Location: Xi'an, Shaanxi
Market orientation: Global supply of plant extracts, cosmetic ingredients, and related nutritional materials.
Aogubio publishes an Ethylhexyl Methoxycinnamate product listing and operates a broad ingredient-supply business.
Its range may appeal to purchasers sourcing both botanical actives and conventional functional ingredients. However, the origin and manufacturing controls for Octinoxate must be evaluated separately from the company's extraction capabilities.
Buyer fit: Companies consolidating several categories of cosmetic raw materials.
OEM/ODM scope: Confirm any proposed custom packaging, formulation, or development service in writing, including which entity performs the work.
Qualification priority: Reconcile corporate and factory histories, identify the Octinoxate manufacturer, and request product-specific evidence. Generic certification language on a catalog page is not a substitute for a valid, relevant certificate.
Established: 2006 for the parent company
Location: Shanghai
Market orientation: A diversified chemical and industrial materials business; Octinoxate-specific destination markets require confirmation.
JIN DUN publishes an Ethylhexyl Methoxycinnamate product page. Its broader corporate description emphasizes chemical materials development rather than exclusively sun-care ingredients.
This makes it a candidate for procurement teams comfortable qualifying a diversified chemical supplier.
Buyer fit: Industrial purchasing organizations able to conduct detailed product and site assessments.
OEM/ODM scope: Ask about specification customization and contract supply. Finished cosmetic development is not established by the product listing.
Qualification priority: Confirm the exact seller and producer, cosmetic-grade suitability, analytical capabilities, and whether supplied documentation is issued by the original manufacturer.
Established: 1995
Location: Shanghai
Market orientation: Global and regional fine-chemical customers; its Octinoxate page references international supply.
Freemen describes its business around integrating resources to provide competitive fine-chemical products. Its Octinoxate page supports inclusion as a sourcing candidate, but does not independently establish an owned Octinoxate production line.
Buyer fit: Purchasers seeking supply-chain coordination and commercial sourcing support.
OEM/ODM scope: Discuss contract sourcing, packaging, and specification management directly. Do not assume finished-product manufacturing capability.
Qualification priority: Require disclosure of the actual factory and a quality agreement preventing unapproved changes to manufacturer, production site, or grade.
| Company | Procurement focus | Octinoxate-specific capacity | Octinoxate MOQ | Public quality-system information |
|---|---|---|---|---|
| ZHENYIBIO | Broader ingredient sourcing and development coordination | Not verified | Obtain quotation | Lists quality-system and other credentials; verify current documents and scope |
| COSMOS | Manufacturing-oriented personal-care ingredients | Confirm grade and allocation | Obtain quotation | States EFfCI certification |
| MFCI | Specialist UV-filter supply | Company scale disclosed; OMC capacity not established | Obtain quotation | Describes GMP/cGMP controls and historical FDA audit |
| Disheng | Fine chemicals and cosmetic UV filters | Not verified | Obtain quotation | Request current site-specific certificates |
| Uniproma | Named UV-filter grades and international supply | Confirm production site and allocation | Obtain quotation | Request certificates applicable to Sunsafe-OMC |
| COSROMA | Integrated ingredient supply | Confirm underlying manufacturer | Obtain quotation | Verify original producer's credentials |
| Greenway | Ingredient supply through manufacturing relationships | Confirm manufacturing partner | Obtain quotation | Describes ISO/GMP production facilities; verify covered entities |
| Aogubio | Broad cosmetic and botanical ingredient sourcing | Not verified | Obtain quotation | Request product-relevant certificates |
| JIN DUN | Diversified chemical procurement | Not verified | Obtain quotation | Request manufacturing-site evidence |
| Freemen | Fine-chemical sourcing coordination | Confirm underlying manufacturer | Obtain quotation | Verify producer and commercial handling controls |
For a meaningful commercial comparison, issue the same request to every shortlisted supplier. Specify annual demand, first-order quantity, destination, packaging, approved specification, and documentation requirements.
Compare available allocation rather than headline plant capacity. A large factory may have limited uncommitted production during peak demand.
Ask for the legal manufacturer's name and address before approving the material.
Match that information against:
- The business license.
- Certificate holder and covered site.
- Product specification and batch COA.
- Audit report or qualification questionnaire.
- Manufacturing-origin declaration.
- Quality agreement.
If the commercial seller differs from the producer, define who handles complaints, deviations, recalls, and technical investigations.
Use a sequence that connects evaluation samples to commercial deliveries:
1. Review the proposed specification and test methods.
2. Obtain a sample with its batch number and COA.
3. Conduct independent identity and specification testing.
4. Evaluate the material in the intended formulation.
5. Review stability and finished-product performance.
6. Place a controlled trial order.
7. Compare the incoming commercial batch against the approved reference.
A successful raw-material sample does not establish the finished sunscreen's SPF, UVA protection, water resistance, or shelf life.
"OEM/ODM" can refer to very different deliverables.
For raw materials, it may mean custom specifications, packaging, blends, or coordinated sourcing. For finished sunscreens, it may mean formulation development, filling, labeling, testing, and regulatory support.
Write these responsibilities into the quotation. Identify who owns the formulation, who commissions performance testing, and who bears the cost if the product fails agreed acceptance criteria.
Require packaging and shipping conditions consistent with the supplier's approved SDS and storage instructions.
The purchase agreement should address:
- Container and seal identification.
- Packaging compatibility.
- Storage and transport conditions.
- Remaining shelf life on arrival.
- Shipment documentation.
- Incoterms and insurance.
- Procedures for damaged, leaking, or delayed consignments.
Transport classification should be established from the actual grade's SDS and the applicable route and mode, rather than copied from an unrelated supplier's listing.
A particularly important risk is approving one manufacturer's sample and later receiving material from another factory under the same seller's product name.
The new batch may still meet a broad assay requirement. Nevertheless, its impurity profile, odor, color, or formulation behavior may differ enough to create development or consistency problems.
This is a procurement risk-control scenario, not an allegation about any company listed here.
Prevent it through a written change-control clause covering:
- Original manufacturer.
- Production site.
- Approved grade and specification.
- Relevant analytical methods.
- Changes to manufacturing or purification that could affect quality.
- Advance notification and buyer approval requirements.
Retain reference samples and compare commercial batches using agreed methods. Qualify the supply chain behind the sample, not merely the sample itself.
The European Commission's SCCS final opinion, adopted on June 26, 2025, concluded that EHMC is safe at up to 10% in the specified sunscreen, face, hand, and lip products under its assessment. The official page also records a March 26, 2026 corrigendum.
The opinion acknowledges endocrine activity in the evidence reviewed. Its conclusion should therefore be described accurately, rather than simplified into an unrestricted safety claim. It also explicitly excludes environmental safety from the assessment.
A scientific opinion is not a substitute for checking the current legislation applicable when the finished product enters the market.
FDA's sunscreen materials distinguish the deemed final order from proposed revisions. The agency's proposed framework identifies Octinoxate among ingredients needing additional data to support a generally recognized as safe and effective determination. That proposed status should not be presented as a blanket ban.
Buyers targeting the United States should check the operative federal requirements and any applicable local restrictions with their regulatory team before approving the formulation.
There is no single supplier model that suits every Octinoxate buyer.
Specialist manufacturers deserve attention when production controls and long-term allocation dominate the decision. Integrated ingredient suppliers may be more practical when buyers need coordinated purchasing, application support, and management of a broader raw-material portfolio.
For ZHENYIBIO, the credible proposition is a collaborative ingredient-sourcing relationship built around documented specifications, transparent manufacturing origin, and clearly scoped OEM/ODM support—not an unsupported claim of superior Octinoxate capacity.
Send ZHENYIBIO your destination market, annual forecast, first-order quantity, packaging requirements, and intended application. Request an Octinoxate technical dossier, traceable sample, current applicable certificates, and a written service proposal before moving to commercial qualification.
Obtain the complete certificate, including its number, issuing body, standard, scope, covered sites, and dates.
Use the issuing body's verification service and an accredited-certificate database where available. IAF CertSearch provides status information including active, suspended, withdrawn, and expired, together with certification scope and issuing-body details.
If a record is missing, contact the issuer rather than immediately declaring the certificate fraudulent. Also check that the certificate covers the actual manufacturer and activity—not merely the supplier's office.
An assay result alone does not capture every purchasing requirement. Compare identity, UV absorption, relevant impurities, color, odor, and formulation behavior under agreed methods.
Uniproma's publication of a specific UV absorption requirement illustrates why buyers should review functional specifications alongside purity.
Evaluate differences in your actual formulation before accepting a supplier substitution.
A distributor can still be qualified if it provides sufficient manufacturer-origin evidence and accepts enforceable quality responsibilities.
Require the producer's identity, manufacturing-site documents, batch-level records, complaint procedures, and written change control. Where necessary, arrange a three-party quality agreement.
Do not equate a distributor model with poor quality. The critical issue is whether accountability and traceability remain intact.
No. Inspection history, establishment-related requirements, ingredient status, and finished-product compliance are different questions.
FDA explains that lawful OTC sunscreen marketing depends on conformity with applicable requirements, while proposed revisions address additional safety-data needs for several ingredients, including Octinoxate.
Request evidence relevant to your product and intended use rather than accepting "FDA certified" as a complete answer.
Not by itself.
The SCCS expressly states that its EHMC assessment did not cover environmental safety. Its human-safety conclusion therefore cannot substantiate a marine-environment claim.
Before adopting environmental language, obtain evidence relevant to the precise claim and intended market. Separate ingredient sourcing claims, manufacturing sustainability claims, and finished-product environmental claims.
- European Commission: Final SCCS opinion on Ethylhexyl Methoxycinnamate, including the recorded 2026 corrigendum. [health.ec.europa]
- Cosmetics Europe: Annual Report 2024, published in 2025, with European cosmetics and personal-care market figures. [cosmeticseurope]
- General Administration of Customs of China: Published explanation containing 2025 cosmetics import-and-export figures. [gjs.customs.gov]
- US FDA: Regulatory actions on OTC sunscreen products and the distinction between operative and proposed requirements. [fda]
- IAF CertSearch: Certificate-status verification and scope review. [iafcertsearch]
- ZHENYIBIO: Corporate profile and ingredient portfolio. [zhenyibio]
- COSMOS: Corporate capabilities and stated EFfCI certification. [cosmoschem]
- MFCI: Manufacturing history, quality-system description, and company footprint. [uvabsorbers]
- Disheng: Corporate background and DSUNPRO OMC listing. [dishengchemchina]
- Uniproma: Corporate history and Sunsafe-OMC technical information. [uniproma]
- COSROMA: Business-model disclosure and UV-filter portfolio. [cosroma]
- Greenway: Corporate description and Ethylhexyl Methoxycinnamate listing. [greenwaybiochem]
- Aogubio: Corporate background and ingredient listing. [aogubio]
- JIN DUN: Parent-company background and Ethylhexyl Methoxycinnamate listing. [jindunchem-med]
- Freemen: Corporate history and Octinoxate sourcing page. [sfchemicals]
Home Contact Us Products About Us Honors and Certification FAQ